Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19064155 | MEDICAMENT DELIVERY DEVICE | February 2025 | October 2025 | Allow | 7 | 1 | 1 | No | No |
| 18829229 | PRESSURE RIGIDIZATION APPARATUSES AND METHODS | September 2024 | July 2025 | Allow | 10 | 1 | 1 | Yes | No |
| 18739243 | INJECTION DEVICES AND SYSTEMS AND METHODS FOR USING THEM | June 2024 | February 2026 | Allow | 20 | 2 | 1 | No | No |
| 18716499 | COUPLING SYSTEM FOR FLUID TRANSFER | June 2024 | August 2025 | Abandon | 14 | 2 | 0 | No | No |
| 18645975 | Genderless Aseptic Connector | April 2024 | December 2024 | Allow | 8 | 1 | 0 | No | No |
| 18638166 | MEDICAMENT DELIVERY DEVICE | April 2024 | February 2025 | Allow | 10 | 1 | 0 | Yes | No |
| 18603079 | SYRINGE STABILIZER | March 2024 | February 2026 | Allow | 23 | 1 | 0 | No | No |
| 18590711 | ATTACHMENT MECHANISM, MODULE AND ASSEMBLY HEREWITH | February 2024 | March 2025 | Allow | 13 | 2 | 1 | No | No |
| 18406013 | SYSTEM AND METHOD FOR DRAWING A SOLUTION | January 2024 | December 2025 | Allow | 23 | 3 | 0 | No | No |
| 18394502 | FLUIDICS MANAGEMENT SYSTEM | December 2023 | October 2024 | Allow | 10 | 2 | 0 | Yes | No |
| 18502803 | DEVICES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISCOGENIC BACK PAIN | November 2023 | September 2024 | Allow | 11 | 1 | 0 | Yes | No |
| 18497142 | SYSTEM AND METHODS FOR INTRACRANIAL VESSEL ACCESS | October 2023 | March 2026 | Allow | 28 | 4 | 0 | Yes | No |
| 18374288 | DRUG DELIVERY DEVICE HAVING A NEEDLE GUARD MECHANISM WITH A TURNABLE THRESHOLD OF RESISTANCE TO NEEDLE GUARD MOVEMENT | September 2023 | December 2025 | Allow | 27 | 5 | 0 | No | No |
| 18552893 | ASPIRATION AND INJECTION DEVICES | September 2023 | July 2024 | Allow | 10 | 1 | 1 | Yes | No |
| 18238348 | INFUSION DEVICE AND METHOD | August 2023 | December 2024 | Allow | 15 | 1 | 1 | No | No |
| 18229963 | ENDOVASCULAR REMOTELY STEERABLE GUIDEWIRE CATHETER | August 2023 | September 2024 | Allow | 13 | 1 | 0 | No | No |
| 18361716 | INTRAOCULAR IMPLANT DELIVERY APPARATUS AND METHODS OF USE THEREOF | July 2023 | July 2025 | Abandon | 23 | 1 | 1 | No | No |
| 18358147 | ACTIVATION SYSTEM AND METHOD FOR ON-BODY MEDICAL DEVICES | July 2023 | December 2024 | Allow | 17 | 1 | 1 | Yes | No |
| 18358229 | FLOW INDICATOR FOR AN INFUSION PUMP | July 2023 | August 2024 | Allow | 13 | 1 | 0 | No | No |
| 18141680 | APPARATUS AND METHODS FOR DISPENSING ORAL TRANSMUCOSAL DOSAGE FORMS | May 2023 | March 2025 | Abandon | 23 | 3 | 0 | No | No |
| 18139698 | Integrated Pump Control For Dynamic Control Of Plasma Field | April 2023 | March 2024 | Allow | 11 | 1 | 0 | Yes | No |
| 18043873 | CATHETERS ADAPTED FOR AGENT DELIVERY | March 2023 | February 2025 | Allow | 24 | 2 | 1 | No | No |
| 18041104 | Features for Angiography Syringe | February 2023 | March 2024 | Allow | 14 | 2 | 1 | No | No |
| 18107422 | HIATAL HERNIA TREATMENT | February 2023 | May 2024 | Allow | 15 | 1 | 1 | Yes | No |
| 18095601 | DELIVERY DEVICE | January 2023 | August 2025 | Allow | 31 | 5 | 0 | No | No |
| 18092838 | METHOD AND DEVICE FOR SECLUDING A BODY VESSEL | January 2023 | August 2025 | Abandon | 31 | 3 | 0 | No | No |
| 18073126 | INTRAVENOUS PRIMING CAP | December 2022 | February 2024 | Allow | 14 | 1 | 0 | Yes | No |
| 17981998 | Adaptor for Connecting a Drug Delivery Device to a Connector | November 2022 | August 2025 | Allow | 33 | 4 | 0 | Yes | No |
| 18048783 | DRUG DEPOT DELIVERY SYSTEM AND METHOD | October 2022 | February 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 17931162 | DRUG DELIVERY DEVICE AND METHOD | September 2022 | November 2023 | Allow | 14 | 2 | 0 | Yes | No |
| 17901360 | INFUSING DRUG SOLUTION DIRECTLY INTO BRAIN FLUID | September 2022 | April 2025 | Allow | 31 | 4 | 0 | Yes | Yes |
| 17886199 | HIGH FLEXIBILITY, KINK RESISTANT CATHETER SHAFT | August 2022 | February 2026 | Allow | 43 | 5 | 0 | Yes | No |
| 17860574 | IN VIVO POSITIONABLE FILTRATION DEVICES AND METHODS RELATED THERETO | July 2022 | March 2024 | Allow | 20 | 2 | 0 | Yes | No |
| 17856758 | IMPLANTABLE CRANIAL MEDICAL DEVICE | July 2022 | March 2026 | Abandon | 45 | 1 | 0 | No | No |
| 17834478 | Auto-Injector with Cap | June 2022 | November 2025 | Allow | 41 | 3 | 0 | Yes | No |
| 17778176 | DOSING SYRINGE | May 2022 | January 2026 | Allow | 44 | 1 | 0 | Yes | No |
| 17734551 | METHOD FOR ELECTROPORATION CONTROLLED BY ELECTRICAL IMPEDENCE MEASUREMENTS | May 2022 | January 2024 | Allow | 20 | 1 | 1 | Yes | No |
| 17773310 | FIXED DOSE INJECTION DEVICE | April 2022 | January 2026 | Allow | 45 | 1 | 0 | Yes | No |
| 17703828 | AUTO SHUT OFF MALE LUER FITTING | March 2022 | December 2025 | Allow | 45 | 1 | 1 | Yes | No |
| 17640862 | TRACK AND LOCKING MECHANISMS FOR INJECTION DEVICE | March 2022 | February 2024 | Allow | 24 | 1 | 0 | Yes | No |
| 17637936 | INJECTOR SYSTEM FOR DELIVERY OF A MEDICAL IMPLANT | February 2022 | December 2025 | Abandon | 45 | 1 | 0 | No | No |
| 17679063 | Fenestrated infusion balloon catheter and methods of use | February 2022 | July 2025 | Allow | 41 | 1 | 1 | Yes | No |
| 17637413 | NEEDLELESS SYRINGE HAVING MULTI-NOZZLE AND MANUFACTURING METHOD THEREFOR | February 2022 | January 2026 | Allow | 47 | 2 | 0 | No | No |
| 17673675 | INJECTION DEVICES AND SYSTEMS AND METHODS FOR USING THEM | February 2022 | February 2024 | Allow | 24 | 1 | 1 | Yes | No |
| 17668572 | LAPAROSCOPIC ACCESS DEVICE WITH REAL-TIME MEASUREMENTS | February 2022 | September 2025 | Allow | 43 | 1 | 1 | No | No |
| 17666138 | Implants for Localized Drug Delivery and Methods of Use Thereof | February 2022 | November 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17629433 | TAMPER-EVIDENT CLOSURE | January 2022 | August 2025 | Allow | 43 | 2 | 0 | No | No |
| 17575560 | Retrograde Blood Flow Occlusion Flushing Device | January 2022 | September 2025 | Abandon | 44 | 5 | 1 | Yes | No |
| 17457722 | INTRAOCULAR GAS INJECTOR | December 2021 | June 2023 | Allow | 19 | 1 | 0 | No | No |
| 17542218 | ACTIVATION SYSTEM AND METHOD FOR ON-BODY MEDICAL DEVICES | December 2021 | May 2023 | Allow | 17 | 1 | 0 | No | No |
| 17457006 | SYSTEM AND METHODS FOR INTRACRANIAL VESSEL ACCESS | November 2021 | July 2023 | Allow | 20 | 1 | 0 | Yes | No |
| 17526268 | MEDICAMENT DELIVERY DEVICE | November 2021 | January 2024 | Allow | 26 | 1 | 1 | Yes | No |
| 17520397 | MALE LUER WITH FLUID PATH AND VENT PATH SEALS | November 2021 | April 2025 | Allow | 41 | 2 | 0 | No | No |
| 17449221 | OCCLUDABLE INTRODUCER NEEDLE | September 2021 | March 2023 | Allow | 18 | 1 | 0 | Yes | No |
| 17426035 | AUTO-INJECTOR WITH CAP | August 2021 | November 2025 | Allow | 52 | 3 | 0 | Yes | No |
| 17404954 | SYRINGE ADAPTER FOR MEDICATION | August 2021 | May 2022 | Allow | 9 | 2 | 0 | Yes | No |
| 17391685 | CANNULAS HAVING WALL STRENGTHENING FEATURES, AND RELATED SYSTEMS AND METHODS | August 2021 | April 2025 | Allow | 45 | 4 | 1 | Yes | No |
| 17340840 | CHAMBERED DISPENSING DEVICES AND METHODS | June 2021 | May 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17309290 | Syringe For Storing And Dispensing A Material | May 2021 | March 2025 | Allow | 46 | 4 | 0 | No | No |
| 17241927 | MICROPROJECTION ARRAYS WITH ENHANCED SKIN PENETRATING PROPERTIES AND METHODS THEREOF | April 2021 | May 2024 | Allow | 37 | 3 | 0 | Yes | No |
| 17286210 | Magnetic Delivery System and Hydrogel Fixative for Therapeutic Cells | April 2021 | December 2024 | Allow | 44 | 1 | 1 | Yes | No |
| 17280399 | AUTO-INJECTOR | March 2021 | December 2024 | Allow | 45 | 2 | 0 | Yes | No |
| 17278968 | AUTO-INJECTOR | March 2021 | March 2026 | Allow | 60 | 3 | 1 | Yes | No |
| 17278894 | FIXING DEVICE FOR FIXING A CATHETER ASSEMBLY TO A PATIENT | March 2021 | January 2025 | Allow | 46 | 5 | 0 | No | No |
| 17270616 | FLUID INJECTOR SYSTEM WITH IMPROVED RATIO PERFORMANCE | February 2021 | June 2025 | Allow | 51 | 1 | 1 | Yes | No |
| 17269847 | DELIVERY DEVICE FOR MEDICAL TUBULAR BODY | February 2021 | January 2026 | Abandon | 59 | 2 | 1 | Yes | No |
| 17150086 | METHOD AND SYSTEM FOR NEUROHYDRODISSECTION | January 2021 | July 2024 | Allow | 42 | 1 | 0 | Yes | No |
| 17259976 | PLATE ELECTRODES | January 2021 | May 2025 | Abandon | 52 | 1 | 1 | No | No |
| 17147041 | LOCKABLE ADAPTER ASSEMBLY | January 2021 | October 2024 | Allow | 45 | 3 | 0 | No | No |
| 17128122 | Syringe for Direct Use with Medical Ampoules and Vials | December 2020 | July 2023 | Abandon | 31 | 1 | 0 | No | No |
| 17122881 | CATHETER HANDLE | December 2020 | January 2025 | Allow | 49 | 3 | 0 | Yes | No |
| 17252165 | PEN NEEDLE | December 2020 | November 2024 | Allow | 47 | 1 | 1 | No | No |
| 17110588 | Focusing Catheter | December 2020 | December 2025 | Allow | 60 | 3 | 1 | Yes | No |
| 17101135 | SURGICAL ACCESS DEVICE WITH FIXATION MECHANISM | November 2020 | July 2024 | Allow | 44 | 1 | 1 | No | No |
| 16951987 | DRUG DELIVERY DEVICE HAVING A NEEDLE GUARD MECHANISM WITH A TUNABLE THRESHOLD OF RESISTANCE TO NEEDLE GUARD MOVEMENT | November 2020 | September 2023 | Allow | 34 | 8 | 0 | Yes | No |
| 17099925 | Active Injection Guide | November 2020 | July 2024 | Allow | 44 | 3 | 1 | Yes | No |
| 17098933 | MEDICATION DELIVERY SYSTEM WITH MASK | November 2020 | January 2024 | Allow | 38 | 2 | 0 | Yes | No |
| 17088937 | Dosing Control Coupling for Enteral Fluid Transfer and Enteral Couplings and Syringes | November 2020 | September 2025 | Allow | 58 | 6 | 1 | Yes | No |
| 17079291 | CATHETER DEVICES WITH VALVES AND RELATED METHODS | October 2020 | October 2025 | Abandon | 59 | 2 | 1 | No | No |
| 17048615 | DEVICE FOR INJECTING A SUBSTANCE INTO AN INTERLAYER OF A BODY TISSUE OR ORGAN | October 2020 | August 2025 | Allow | 58 | 6 | 0 | No | Yes |
| 17046530 | INJECTION NEEDLE AND INJECTION DEVICE | October 2020 | November 2025 | Abandon | 60 | 4 | 0 | Yes | No |
| 17066867 | APPLICATOR FOR APPLYING A MICRONEEDLE DEVICE TO SKIN | October 2020 | January 2025 | Allow | 51 | 2 | 1 | No | No |
| 17063442 | SYSTEMS FOR INHIBITING HETEROTOPIC OSSIFICATION | October 2020 | August 2025 | Allow | 59 | 3 | 1 | Yes | No |
| 17060769 | Methods and Compositions for Restoring Homeostatic Capacity of a Subject | October 2020 | August 2024 | Allow | 46 | 5 | 1 | Yes | No |
| 17035927 | DRUG DELIVERY DEVICE | September 2020 | April 2024 | Allow | 42 | 4 | 0 | Yes | No |
| 17035851 | DRUG DELIVERY DEVICE AND METHODS OF DELIVERING A DRUG | September 2020 | December 2024 | Allow | 50 | 4 | 1 | Yes | No |
| 17033359 | HIATAL HERNIA TREATMENT | September 2020 | January 2023 | Allow | 27 | 1 | 1 | No | No |
| 17009874 | RELEASABLE SEAL FOR CATHETER SYSTEM | September 2020 | August 2022 | Allow | 24 | 1 | 0 | No | No |
| 16977213 | OPTIMIZING INITIAL ORGAN PRESERVATION | September 2020 | December 2024 | Allow | 51 | 2 | 1 | Yes | No |
| 17004753 | SUBMUCOSAL BIORESORBABLE DRUG ELUTING PLATFORM | August 2020 | April 2025 | Allow | 56 | 3 | 1 | Yes | No |
| 17002078 | INTRAOCULAR IMPLANT DELIVERY APPARATUS AND METHODS OF USE THEREOF | August 2020 | September 2023 | Abandon | 37 | 2 | 0 | No | No |
| 16998176 | PENILE INJECTION GUIDE AND COMPRESSION DEVICE | August 2020 | August 2023 | Allow | 36 | 1 | 0 | Yes | No |
| 16994151 | CONNECTION MECHANISM FOR AN AUXILIARY MODULE | August 2020 | June 2025 | Allow | 58 | 4 | 1 | Yes | No |
| 16992009 | Automated sequential injection and blood draw | August 2020 | May 2024 | Abandon | 45 | 2 | 0 | No | No |
| 16965865 | Surface Texturization for Rolling Diaphragm Syringe | July 2020 | February 2025 | Abandon | 54 | 6 | 1 | Yes | No |
| 16942459 | CATHETER SHAFT AND CATHETER AND METHOD FOR THE PRODUCTION THEREOF | July 2020 | April 2025 | Allow | 56 | 4 | 0 | No | No |
| 16936763 | EXPANDABLE SHEATH | July 2020 | October 2025 | Allow | 60 | 3 | 0 | No | No |
| 16918273 | Flow Indicator for an Infusion Pump | July 2020 | April 2023 | Allow | 34 | 1 | 1 | Yes | No |
| 16908387 | RIGID AND FLEXIBLE LAPAROSCOPIC MULTIPLE COMPONENT MATERIAL DISPENSING DEVICES AND METHODS | June 2020 | June 2024 | Allow | 48 | 2 | 1 | No | No |
| 16772229 | READY-TO-USE CRYORESISTANT INJECTION DEVICE | June 2020 | April 2023 | Abandon | 34 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LALONDE, ALEXANDRA ELIZABETH.
With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 17.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner LALONDE, ALEXANDRA ELIZABETH works in Art Unit 3783 and has examined 302 patent applications in our dataset. With an allowance rate of 70.2%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 42 months.
Examiner LALONDE, ALEXANDRA ELIZABETH's allowance rate of 70.2% places them in the 32% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by LALONDE, ALEXANDRA ELIZABETH receive 3.05 office actions before reaching final disposition. This places the examiner in the 88% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LALONDE, ALEXANDRA ELIZABETH is 42 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +34.6% benefit to allowance rate for applications examined by LALONDE, ALEXANDRA ELIZABETH. This interview benefit is in the 82% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 21.2% of applications are subsequently allowed. This success rate is in the 25% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 20.6% of cases where such amendments are filed. This entry rate is in the 25% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 60.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 50% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 76.5% of appeals filed. This is in the 68% percentile among all examiners. Of these withdrawals, 69.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.9% of allowed cases (in the 60% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.